Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for SNDX

Stock NameSyndax Pharmaceuticals Inc
TickerSNDX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS87164F1057
LEI529900OF94TRHKZVBS87

Show aggregate SNDX holdings

News associated with SNDX

Syndax Pharmaceuticals (NASDAQ:SNDX) Now Covered by Stifel Nicolaus
Stifel Nicolaus began coverage on shares of Syndax Pharmaceuticals (NASDAQ:SNDX – Free Report) in a research report released on Wednesday, MarketBeat.com reports. The brokerage issued a buy rating and a $44.00 price target on the stock. Several other brokerages have also issued reports on SNDX. BTIG Research raised their target price on Syndax Pharmaceuticals from […] - 2025-09-11 04:40:27
Analysts Set Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Target Price at $36.91
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) has been given a consensus rating of “Buy” by the twelve research firms that are currently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the […] - 2025-08-13 03:14:52
Traders Purchase Large Volume of Call Options on Syndax Pharmaceuticals (NASDAQ:SNDX)
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) was the recipient of unusually large options trading on Tuesday. Stock investors acquired 13,389 call options on the company. Thisrepresentsanincreaseof904% compared to the typical daily volume of 1,333 call options. Analysts Set New Price Targets A number of research analysts recently weighed in on SNDX shares. Citigroup […] - 2025-08-13 02:14:52
Zurcher Kantonalbank Zurich Cantonalbank Sells 4,731 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
Zurcher Kantonalbank Zurich Cantonalbank cut its holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 26.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,260 shares of the company’s stock after selling 4,731 shares during the quarter. Zurcher Kantonalbank Zurich […] - 2025-08-11 05:21:01
Syndax Pharmaceuticals (NASDAQ:SNDX) Shares Gap Up After Better-Than-Expected Earnings
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) gapped up prior to trading on Tuesday following a stronger than expected earnings report. The stock had previously closed at $10.38, but opened at $12.41. Syndax Pharmaceuticals shares last traded at $12.02, with a volume of 1,551,513 shares traded. The company reported ($0.83) earnings per share (EPS) […] - 2025-08-07 02:13:02
UBS Group Cuts Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target to $35.00
Syndax Pharmaceuticals (NASDAQ:SNDX – Free Report) had its price objective trimmed by UBS Group from $37.00 to $35.00 in a report published on Tuesday morning,Benzinga reports. The firm currently has a buy rating on the stock. Several other research firms also recently weighed in on SNDX. Scotiabank upped their price objective on shares of Syndax […] - 2025-07-18 05:05:16
Syndax Pharmaceuticals (NASDAQ:SNDX) Shares Down 6% After Analyst Downgrade
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) dropped 6% during mid-day trading on Tuesday after UBS Group lowered their price target on the stock from $37.00 to $35.00. UBS Group currently has a buy rating on the stock. Syndax Pharmaceuticals traded as low as $9.30 and last traded at $9.26. Approximately 282,152 shares were […] - 2025-07-16 02:46:49
Wealth Enhancement Advisory Services LLC Invests $162,000 in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
Wealth Enhancement Advisory Services LLC acquired a new position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 13,172 shares of the company’s stock, valued at approximately $162,000. A number of other institutional investors and hedge […] - 2025-07-10 04:20:57
KBC Group NV Sells 1,774 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
KBC Group NV decreased its position in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 25.5% during the 1st quarter, Holdings Channel reports. The institutional investor owned 5,180 shares of the company’s stock after selling 1,774 shares during the quarter. KBC Group NV’s holdings in Syndax Pharmaceuticals were worth $64,000 as of its […] - 2025-07-09 04:33:51
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives $35.91 Average PT from Analysts
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) has earned an average rating of “Moderate Buy” from the eleven ratings firms that are covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating and ten have given a buy rating to the company. The average 1 year price […] - 2025-06-24 02:36:53
ProShare Advisors LLC Has $359,000 Stock Holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
ProShare Advisors LLC grew its holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 32.2% during the fourth quarter, Holdings Channel reports. The firm owned 27,183 shares of the company’s stock after acquiring an additional 6,627 shares during the quarter. ProShare Advisors LLC’s holdings in Syndax Pharmaceuticals were worth $359,000 at the end of […] - 2025-05-29 05:04:57
Millennium Management LLC Sells 533,153 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
Millennium Management LLC trimmed its position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 47.6% during the fourth quarter, HoldingsChannel.com reports. The fund owned 586,810 shares of the company’s stock after selling 533,153 shares during the quarter. Millennium Management LLC’s holdings in Syndax Pharmaceuticals were worth $7,758,000 at the end of the most recent […] - 2025-05-27 04:54:51
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Average Rating of “Moderate Buy” from Analysts
Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) have been given a consensus rating of “Moderate Buy” by the eleven ratings firms that are currently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and ten have given a buy recommendation to the company. […] - 2025-05-27 02:49:01
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares Sold by Schonfeld Strategic Advisors LLC
Schonfeld Strategic Advisors LLC reduced its stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 89.0% in the fourth quarter, HoldingsChannel.com reports. The fund owned 20,657 shares of the company’s stock after selling 166,806 shares during the quarter. Schonfeld Strategic Advisors LLC’s holdings in Syndax Pharmaceuticals were worth $273,000 as of its most recent […] - 2025-05-13 06:15:02
Dimensional Fund Advisors LP Has $4.38 Million Stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
Dimensional Fund Advisors LP increased its stake in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 594.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 331,300 shares of the company’s stock after buying an additional 283,577 shares during the […] - 2025-05-13 04:38:47
Tuesday's ETF Movers: TAN, XBI
In trading on Tuesday, the Invesco Solar ETF is outperforming other ETFs, up about 3.2% on the day. Components of that ETF showing particular strength include shares of Shoals Technologies Group, up about 19.8% and shares of Solaredge Technologies, up about 16.3% on the day. A - 2025-05-06 13:09:13
Marshall Wace LLP Decreases Stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
Marshall Wace LLP lessened its holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 98.7% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 12,624 shares of the company’s stock after selling 977,280 shares during the period. Marshall Wace LLP’s holdings in Syndax […] - 2025-05-06 04:44:58
Tower Research Capital LLC TRC Has $240,000 Holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
Tower Research Capital LLC TRC boosted its stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 179.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 18,190 shares of the company’s stock after purchasing an additional 11,681 shares during the period. Tower […] - 2025-05-05 05:30:49
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives $36.20 Consensus Price Target from Brokerages
Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) have earned an average rating of “Moderate Buy” from the ten brokerages that are presently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and nine have assigned a buy rating to the company. The average 1-year price […] - 2025-05-05 02:49:06
Geode Capital Management LLC Sells 3,966 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
Geode Capital Management LLC trimmed its position in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 0.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,973,116 shares of the company’s stock after selling 3,966 shares during the period. […] - 2025-04-18 04:34:51
KLP Kapitalforvaltning AS Invests $219,000 in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
KLP Kapitalforvaltning AS acquired a new stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) in the fourth quarter, HoldingsChannel.com reports. The firm acquired 16,600 shares of the company’s stock, valued at approximately $219,000. Other institutional investors have also recently added to or reduced their stakes in the company. R Squared Ltd acquired a new […] - 2025-04-08 05:04:47
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares Acquired by Teacher Retirement System of Texas
Teacher Retirement System of Texas lifted its holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 18.7% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 22,769 shares of the company’s stock after purchasing an additional 3,585 shares during the period. Teacher Retirement System of Texas’ holdings in Syndax Pharmaceuticals were worth $301,000 […] - 2025-04-02 04:42:46
Signaturefd LLC Cuts Holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
Signaturefd LLC lessened its stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 45.6% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 2,078 shares of the company’s stock after selling 1,745 shares during the quarter. Signaturefd LLC’s holdings in Syndax Pharmaceuticals were worth $27,000 as of […] - 2025-03-26 05:48:52
Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Up 5.5% on Analyst Upgrade
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) shares shot up 5.5% on Thursday after JPMorgan Chase & Co. raised their price target on the stock from $39.00 to $41.00. JPMorgan Chase & Co. currently has an overweight rating on the stock. Syndax Pharmaceuticals traded as high as $13.51 and last traded at $13.84. 164,424 […] - 2025-03-21 03:42:50
Syndax Pharmaceuticals (NASDAQ:SNDX) Trading Down 7.4% on Disappointing Earnings
Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) were down 7.4% during trading on Tuesday following a weaker than expected earnings announcement. The company traded as low as $14.23 and last traded at $14.34. Approximately 1,069,083 shares were traded during trading, a decline of 53% from the average daily volume of 2,257,449 shares. […] - 2025-03-06 06:13:39
Citigroup Lowers Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target to $42.00
Syndax Pharmaceuticals (NASDAQ:SNDX – Free Report) had its price target reduced by Citigroup from $45.00 to $42.00 in a research report sent to investors on Tuesday morning,Benzinga reports. Citigroup currently has a buy rating on the stock. Other research analysts also recently issued reports about the company. The Goldman Sachs Group lifted their target price […] - 2025-03-05 06:45:05
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares Sold by Sanctuary Advisors LLC
Sanctuary Advisors LLC lowered its stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 18.6% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 25,178 shares of the company’s stock after selling 5,750 shares during the quarter. Sanctuary Advisors LLC’s holdings in Syndax Pharmaceuticals were worth $358,000 at the end of the most […] - 2025-03-04 06:20:47
Analysts Set Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Price Target at $36.20
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the ten analysts that are presently covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold rating and nine have issued a buy rating on the company. The average 12-month price objective among […] - 2025-02-19 04:30:59
1,940 Shares in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Acquired by R Squared Ltd
R Squared Ltd purchased a new stake in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) in the fourth quarter, HoldingsChannel reports. The institutional investor purchased 1,940 shares of the company’s stock, valued at approximately $26,000. Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. […] - 2025-02-05 06:42:48

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc SNDX holdings

DateNumber of SNDX Shares HeldBase Market Value of SNDX SharesLocal Market Value of SNDX SharesChange in SNDX Shares HeldChange in SNDX Base ValueCurrent Price per SNDX Share HeldPrevious Price per SNDX Share Held
2025-11-12 (Wednesday)11,677SNDX holding decreased by -38USD 196,057SNDX holding decreased by -11650USD 196,057-38USD -11,650 USD 16.79 USD 17.73
2025-11-11 (Tuesday)11,715USD 207,707SNDX holding increased by 23547USD 207,7070USD 23,547 USD 17.73 USD 15.72
2025-11-10 (Monday)11,715USD 184,160SNDX holding increased by 7966USD 184,1600USD 7,966 USD 15.72 USD 15.04
2025-11-07 (Friday)11,715USD 176,194SNDX holding increased by 4101USD 176,1940USD 4,101 USD 15.04 USD 14.69
2025-11-06 (Thursday)11,715SNDX holding decreased by -38USD 172,093SNDX holding decreased by -5377USD 172,093-38USD -5,377 USD 14.69 USD 15.1
2025-11-05 (Wednesday)11,753SNDX holding decreased by -380USD 177,470SNDX holding decreased by -8772USD 177,470-380USD -8,772 USD 15.1 USD 15.35
2025-11-04 (Tuesday)12,133SNDX holding decreased by -152USD 186,242SNDX holding increased by 17200USD 186,242-152USD 17,200 USD 15.35 USD 13.76
2025-11-03 (Monday)12,285USD 169,042SNDX holding increased by 737USD 169,0420USD 737 USD 13.76 USD 13.7
2025-10-31 (Friday)12,285USD 168,305SNDX holding increased by 3809USD 168,3050USD 3,809 USD 13.7 USD 13.39
2025-10-30 (Thursday)12,285USD 164,496SNDX holding increased by 2088USD 164,4960USD 2,088 USD 13.39 USD 13.22
2025-10-29 (Wednesday)12,285USD 162,408SNDX holding decreased by -3562USD 162,4080USD -3,562 USD 13.22 USD 13.51
2025-10-28 (Tuesday)12,285SNDX holding increased by 114USD 165,970SNDX holding increased by 6408USD 165,970114USD 6,408 USD 13.51 USD 13.11
2025-10-27 (Monday)12,171USD 159,562SNDX holding decreased by -5112USD 159,5620USD -5,112 USD 13.11 USD 13.53
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of SNDX by Blackrock for IE00B3VWM098

Show aggregate share trades of SNDX

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-12SELL-38 16.790* 13.41 Profit of 510 on sale
2025-11-06SELL-38 14.690* 13.36 Profit of 508 on sale
2025-11-05SELL-38015.29014.267 14.369USD -5,460 13.35 Loss of -386 on sale
2025-11-04SELL-152 15.350* 13.34 Profit of 2,028 on sale
2025-10-28BUY11413.51013.990 13.942USD 1,589 13.34
2025-10-24SELL-3813.53015.790 15.564USD -591 13.34 Loss of -85 on sale
2025-10-15BUY22815.04015.790 15.715USD 3,583 13.27
2025-10-02BUY3815.44015.990 15.935USD 606 13.25
2025-09-30BUY7615.38515.815 15.772USD 1,199 13.22
2025-08-21SELL-17015.84016.040 16.020USD -2,723 13.15 Loss of -487 on sale
2025-07-31BUY5109.92010.040 10.028USD 5,114 13.16
2025-06-30SELL-3409.3659.561 9.541USD -3,244 13.64 Profit of 1,393 on sale
2025-06-25SELL-1708.9009.420 9.368USD -1,593 13.73 Profit of 742 on sale
2025-06-20SELL-3409.4809.820 9.786USD -3,327 13.83 Profit of 1,375 on sale
2025-05-23BUY1709.85011.040 10.921USD 1,857 14.39
2025-05-19SELL-1709.3009.350 9.345USD -1,589 14.53 Profit of 881 on sale
2025-05-15SELL-5108.9509.295 9.261USD -4,723 14.62 Profit of 2,734 on sale
2025-05-12SELL-17010.99011.340 11.305USD -1,922 14.74 Profit of 584 on sale
2025-05-09SELL-17010.70011.480 11.402USD -1,938 14.78 Profit of 574 on sale
2025-04-30SELL-17014.15014.240 14.231USD -2,419 14.94 Profit of 121 on sale
2025-04-24SELL-34013.30013.393 13.384USD -4,550 15.00 Profit of 550 on sale
2025-04-17SELL-17011.54011.570 11.567USD -1,966 15.15 Profit of 609 on sale
2025-04-15SELL-51011.33011.605 11.577USD -5,905 15.24 Profit of 1,866 on sale
2025-04-14SELL-51011.24011.470 11.447USD -5,838 15.28 Profit of 1,955 on sale
2025-04-09SELL-68011.52011.840 11.808USD -8,029 15.42 Profit of 2,459 on sale
2025-04-07SELL-1,19011.01011.205 11.185USD -13,311 15.53 Profit of 5,173 on sale
2025-04-04SELL-1,70011.25012.170 12.078USD -20,533 15.58 Profit of 5,958 on sale
2025-03-31BUY17012.28512.980 12.910USD 2,195 15.70
2025-03-19SELL-34013.12013.150 13.147USD -4,470 15.94 Profit of 948 on sale
2025-03-14SELL-1,02012.95013.320 13.283USD -13,549 16.07 Profit of 2,839 on sale
2025-03-13SELL-34413.10013.530 13.487USD -4,640 16.11 Profit of 902 on sale
2025-03-12SELL-5,84813.12013.480 13.444USD -78,621 16.15 Profit of 15,836 on sale
2025-03-07SELL-34413.42014.390 14.293USD -4,917 16.30 Profit of 689 on sale
2025-03-06SELL-51614.29014.565 14.537USD -7,501 16.33 Profit of 923 on sale
2025-03-03SELL-17215.48016.500 16.398USD -2,820 16.40 Profit of 1 on sale
2025-02-28BUY18,10415.64015.745 15.734USD 284,857 16.41
2025-02-26SELL-12115.57016.060 16.011USD -1,937 16.45 Profit of 53 on sale
2025-02-25SELL-36315.24015.850 15.789USD -5,731 16.47 Profit of 247 on sale
2025-02-18BUY60514.62015.144 15.092USD 9,130 16.56
2025-02-13BUY12115.08015.100 15.098USD 1,827 16.66
2025-02-12BUY12114.86015.050 15.031USD 1,819 16.69
2025-02-11BUY36315.01015.445 15.401USD 5,591 16.73
2025-02-06BUY1,08915.82016.580 16.504USD 17,973 16.81
2025-01-27BUY12114.28014.730 14.685USD 1,777 17.35
2024-12-30BUY60512.52012.750 12.727USD 7,700 17.78
2024-12-06BUY48017.01017.155 17.141USD 8,227 17.97
2024-12-05BUY12016.80017.030 17.007USD 2,041 18.01
2024-12-04BUY60016.92017.280 17.244USD 10,346 18.05
2024-11-29BUY60016.72016.920 16.900USD 10,140 18.21
2024-11-27BUY48016.51016.725 16.704USD 8,018 18.36
2024-11-26BUY12016.50016.904 16.864USD 2,024 18.45
2024-11-21BUY60015.60016.270 16.203USD 9,722 18.81
2024-11-20BUY36015.95016.190 16.166USD 5,820 18.97
2024-11-18BUY1,44016.11016.900 16.821USD 24,222 19.35
2024-11-12BUY96016.21017.350 17.236USD 16,547 19.56
2024-11-08BUY60021.81022.020 21.999USD 13,199 19.39
2024-11-07BUY1,80021.52021.930 21.889USD 39,400 19.23
2024-11-06BUY24021.35022.260 22.169USD 5,321 19.05
2024-10-31BUY12018.86019.250 19.211USD 2,305 19.02
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of SNDX

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19369,500716971,43938.0%
2025-09-18483,945500930,18952.0%
2025-09-17261,10721,596608,71442.9%
2025-09-16343,1460840,32740.8%
2025-09-15612,03001,064,63257.5%
2025-09-12229,031110668,41234.3%
2025-09-11427,4940664,64564.3%
2025-09-10259,2690625,21741.5%
2025-09-09179,102300413,79643.3%
2025-09-08153,7330477,01432.2%
2025-09-05347,6360951,26536.5%
2025-09-04234,10513,280630,01037.2%
2025-09-03397,1310939,11442.3%
2025-09-02305,1660802,77638.0%
2025-08-29446,0810757,55258.9%
2025-08-28457,419890973,64247.0%
2025-08-27759,00002,137,19935.5%
2025-08-26352,5970990,87135.6%
2025-08-25278,8900586,52247.5%
2025-08-22313,8950689,39245.5%
2025-08-21145,9610331,74944.0%
2025-08-20488,4641,031744,02565.7%
2025-08-19429,622742823,38052.2%
2025-08-18401,7320776,46551.7%
2025-08-151,458,2417002,711,61853.8%
2025-08-14683,63201,273,29953.7%
2025-08-13362,5620977,71737.1%
2025-08-12370,2097881,021,55736.2%
2025-08-11374,1180922,51740.6%
2025-08-08354,1120835,52942.4%
2025-08-07354,005580924,68638.3%
2025-08-061,370,9651002,749,84549.9%
2025-08-052,387,3472,1724,374,25654.6%
2025-08-04441,42701,363,61232.4%
2025-08-01352,5390610,30257.8%
2025-07-31275,7920877,79631.4%
2025-07-30276,2020906,32630.5%
2025-07-29700,63401,574,58744.5%
2025-07-28255,24020407,85562.6%
2025-07-25217,6580485,99244.8%
2025-07-24201,2930592,43734.0%
2025-07-23334,988100636,66552.6%
2025-07-22438,4830718,58461.0%
2025-07-21366,5110783,92646.8%
2025-07-18384,795300807,54847.6%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.